Search hospitals > Wisconsin > Burlington

Aurora Cancer Care-Southern Lakes VLCC

Claim this profile
Burlington, Wisconsin 53105
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Adenocarcinoma
184 reported clinical trials
21 medical researchers
Photo of Aurora Cancer Care-Southern Lakes VLCC in BurlingtonPhoto of Aurora Cancer Care-Southern Lakes VLCC in BurlingtonPhoto of Aurora Cancer Care-Southern Lakes VLCC in Burlington

Summary

Aurora Cancer Care-Southern Lakes VLCC is a medical facility located in Burlington, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Aurora Cancer Care-Southern Lakes VLCC is involved with conducting 184 clinical trials across 304 conditions. There are 21 research doctors associated with this hospital, such as Rubina Qamar, Thomas J. Saphner, Antony Ruggeri, and Michael A Thompson.

Area of expertise

1Cancer
Global Leader
Aurora Cancer Care-Southern Lakes VLCC has run 79 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Aurora Cancer Care-Southern Lakes VLCC has run 38 trials for Breast Cancer. Some of their research focus areas include:
ER positive
HER2 negative
PR positive

Top PIs

Clinical Trials running at Aurora Cancer Care-Southern Lakes VLCC

Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Prostate Cancer
Bladder Carcinoma
Renal Cell Carcinoma
Rectal Cancer
Ovarian Cancer
Bladder Cancer
Image of trial facility.

Hormone Therapy with or without Radiation

for Breast Cancer

This study is evaluating whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Image of trial facility.

Pembrolizumab

for Triple-Negative Breast Cancer

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Aurora Cancer Care-Southern Lakes VLCC?
Aurora Cancer Care-Southern Lakes VLCC is a medical facility located in Burlington, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Aurora Cancer Care-Southern Lakes VLCC is involved with conducting 184 clinical trials across 304 conditions. There are 21 research doctors associated with this hospital, such as Rubina Qamar, Thomas J. Saphner, Antony Ruggeri, and Michael A Thompson.